Ingavirin (imidazolyl ethanamide pentandioic acid) - Myelo Therap, Valenta Pharm
Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19 (clinicaltrials.gov) - Jan 31, 2022 - P3 | N=290 | Recruiting | Sponsor: Valenta Pharm JSC 
New P3 trial • Infectious Disease • Novel Coronavirus Disease
http://clinicaltrials.gov/ct2/show/NCT05216497
 
Jan 31, 2022
 
Prev Next